Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
M Eriksson, P Reichardt, H Joensuu, A Krarup-Hansen, O Hagberg, P Hohenberger, H Hagberg, L Hansson, T Foukakis, K Pulkkanen, S Bauer, D Goplen, P Blach Rossen, K Sundby Hall
Dyk ned i forskningsemnerne om 'Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)'. Sammen danner de et unikt fingeraftryk.